TRAVERE THERAPEUTICS, INC.: net_income
| Value | {"amount": -110938000, "concept": "us-gaap:NetIncomeLoss", "currency": "USD"} |
|---|---|
| Period | 2014-01-01 – 2014-12-31 |
| Status | current |
| Entity | TRAVERE THERAPEUTICS, INC. |
Provenance
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
Retrieved: 2026-08-19T14:10:32.965170+02:00
Raw response sha256:
Also addressable by official identifiers:
Cite as: FACTANKER, https://factanker.com/fact/30579fdf-68aa-4300-8f70-213b1be751a9
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
0001628280-16-011857Retrieved: 2026-08-19T14:10:32.965170+02:00
Raw response sha256:
f7bde1a401b286c74a2fd824ee1df541…Also addressable by official identifiers:
https://factanker.com/fact/sec/cik-0001438533/net-income/2014-12-31 (CIK, metric, reporting date)Cite as: FACTANKER, https://factanker.com/fact/30579fdf-68aa-4300-8f70-213b1be751a9
History
- supersedes {"amount": -110937862, "concept": "us-gaap:NetIncomeLoss", "currency": "USD"} (evidence 0001571049-15-001817)